That is not how I interpret what Alan is saying - my reading is he is saying CU6 are ahead scientifically of TLX - basically their 67Cu-bis-PSMA drug is better than TLX's alternative.
It is interesting to watch both TLX and CU6 discuss each other's approach to this market. They are taking very different commercialisation approaches and hopefully both companies will do well.
CU6 - General discussion, page-69
-
- There are more pages in this discussion • 333 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
